vs

Side-by-side financial comparison of Knowles Corp (KN) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Knowles Corp is the larger business by last-quarter revenue ($153.1M vs $142.0M, roughly 1.1× Oncology Institute, Inc.). Knowles Corp runs the higher net margin — 6.3% vs -5.3%, a 11.6% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 22.7%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-3.1M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -13.5%).

Knowles Corporation is a global leading designer and manufacturer of advanced micro-acoustic, audio processing, and precision component solutions. It serves core segments including consumer electronics, automotive, medical technology, and industrial markets, offering products such as MEMS microphones, hearing aid components, and edge audio processing ICs to worldwide clients.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

KN vs TOI — Head-to-Head

Bigger by revenue
KN
KN
1.1× larger
KN
$153.1M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+18.9% gap
TOI
41.6%
22.7%
KN
Higher net margin
KN
KN
11.6% more per $
KN
6.3%
-5.3%
TOI
More free cash flow
TOI
TOI
$5.3M more FCF
TOI
$2.2M
$-3.1M
KN
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
-13.5%
KN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
KN
KN
TOI
TOI
Revenue
$153.1M
$142.0M
Net Profit
$9.7M
$-7.5M
Gross Margin
43.8%
Operating Margin
10.4%
-4.9%
Net Margin
6.3%
-5.3%
Revenue YoY
22.7%
41.6%
Net Profit YoY
585.0%
43.0%
EPS (diluted)
$0.13
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KN
KN
TOI
TOI
Q1 26
$153.1M
Q4 25
$162.2M
$142.0M
Q3 25
$152.9M
$136.6M
Q2 25
$145.9M
$119.8M
Q1 25
$132.2M
$104.4M
Q4 24
$142.5M
$100.3M
Q3 24
$142.5M
$99.9M
Q2 24
$204.7M
$98.6M
Net Profit
KN
KN
TOI
TOI
Q1 26
$9.7M
Q4 25
$21.0M
$-7.5M
Q3 25
$17.4M
$-16.5M
Q2 25
$7.8M
$-17.0M
Q1 25
$-2.0M
$-19.6M
Q4 24
$18.5M
$-13.2M
Q3 24
$500.0K
$-16.1M
Q2 24
$-259.3M
$-15.5M
Gross Margin
KN
KN
TOI
TOI
Q1 26
43.8%
Q4 25
44.7%
Q3 25
45.7%
Q2 25
41.5%
Q1 25
40.3%
Q4 24
42.7%
Q3 24
44.1%
Q2 24
28.2%
Operating Margin
KN
KN
TOI
TOI
Q1 26
10.4%
Q4 25
15.9%
-4.9%
Q3 25
16.9%
-5.9%
Q2 25
10.1%
-9.4%
Q1 25
3.0%
-9.5%
Q4 24
10.8%
-11.9%
Q3 24
13.1%
-13.9%
Q2 24
6.2%
-16.6%
Net Margin
KN
KN
TOI
TOI
Q1 26
6.3%
Q4 25
12.9%
-5.3%
Q3 25
11.4%
-12.1%
Q2 25
5.3%
-14.2%
Q1 25
-1.5%
-18.8%
Q4 24
13.0%
-13.1%
Q3 24
0.4%
-16.1%
Q2 24
-126.7%
-15.7%
EPS (diluted)
KN
KN
TOI
TOI
Q1 26
$0.13
Q4 25
$0.23
$-0.04
Q3 25
$0.20
$-0.14
Q2 25
$0.09
$-0.15
Q1 25
$-0.02
$-0.21
Q4 24
$0.20
$-0.14
Q3 24
$0.01
$-0.18
Q2 24
$-2.88
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KN
KN
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$41.0M
Total DebtLower is stronger
$131.0M
Stockholders' EquityBook value
$780.2M
$-15.7M
Total Assets
$1.1B
$164.7M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KN
KN
TOI
TOI
Q1 26
$41.0M
Q4 25
$54.2M
Q3 25
$92.5M
Q2 25
$103.2M
Q1 25
$101.9M
Q4 24
$130.1M
Q3 24
$92.6M
Q2 24
$84.0M
$9.9M
Total Debt
KN
KN
TOI
TOI
Q1 26
$131.0M
Q4 25
$114.0M
Q3 25
$176.3M
Q2 25
$190.0M
Q1 25
$188.8M
Q4 24
$202.5M
Q3 24
$225.0M
Q2 24
$261.2M
Stockholders' Equity
KN
KN
TOI
TOI
Q1 26
$780.2M
Q4 25
$775.8M
$-15.7M
Q3 25
$751.8M
$-12.3M
Q2 25
$746.1M
$-9.0M
Q1 25
$755.8M
$5.1M
Q4 24
$756.0M
$3.6M
Q3 24
$777.4M
$15.5M
Q2 24
$753.0M
$29.2M
Total Assets
KN
KN
TOI
TOI
Q1 26
$1.1B
Q4 25
$1.1B
$164.7M
Q3 25
$1.1B
$163.6M
Q2 25
$1.1B
$159.8M
Q1 25
$1.1B
$164.0M
Q4 24
$1.1B
$172.7M
Q3 24
$1.2B
$179.2M
Q2 24
$1.2B
$179.6M
Debt / Equity
KN
KN
TOI
TOI
Q1 26
0.17×
Q4 25
0.15×
Q3 25
0.23×
Q2 25
0.25×
Q1 25
0.25×
Q4 24
0.27×
Q3 24
0.29×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KN
KN
TOI
TOI
Operating Cash FlowLast quarter
$0
$3.2M
Free Cash FlowOCF − Capex
$-3.1M
$2.2M
FCF MarginFCF / Revenue
-2.0%
1.5%
Capex IntensityCapex / Revenue
7.1%
0.7%
Cash ConversionOCF / Net Profit
0.00×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KN
KN
TOI
TOI
Q1 26
$0
Q4 25
$3.2M
Q3 25
$29.1M
$-12.6M
Q2 25
$36.4M
$-10.2M
Q1 25
$1.3M
$-5.0M
Q4 24
$4.2M
Q3 24
$52.8M
$819.0K
Q2 24
$24.9M
$-15.7M
Free Cash Flow
KN
KN
TOI
TOI
Q1 26
$-3.1M
Q4 25
$2.2M
Q3 25
$21.4M
$-13.2M
Q2 25
$31.3M
$-11.4M
Q1 25
$-2.7M
$-5.3M
Q4 24
$2.4M
Q3 24
$49.1M
$417.0K
Q2 24
$21.7M
$-17.5M
FCF Margin
KN
KN
TOI
TOI
Q1 26
-2.0%
Q4 25
1.5%
Q3 25
14.0%
-9.7%
Q2 25
21.5%
-9.5%
Q1 25
-2.0%
-5.1%
Q4 24
2.4%
Q3 24
34.5%
0.4%
Q2 24
10.6%
-17.7%
Capex Intensity
KN
KN
TOI
TOI
Q1 26
7.1%
Q4 25
9.4%
0.7%
Q3 25
5.0%
0.4%
Q2 25
3.5%
1.0%
Q1 25
3.0%
0.3%
Q4 24
2.3%
1.8%
Q3 24
2.6%
0.4%
Q2 24
1.6%
1.9%
Cash Conversion
KN
KN
TOI
TOI
Q1 26
0.00×
Q4 25
Q3 25
1.67×
Q2 25
4.67×
Q1 25
Q4 24
Q3 24
105.60×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KN
KN

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons